motexafin gadolinium

motexafin gadolinium information and resources from the National Cancer Institute

NCI Thesaurus | motexafin gadolinium

A synthetic metallotexaphyrin with radiosensitizing and chemosensitizing properties. Motexafin gadolinium accumulates in tumor cells preferentially due to their increased rates of metabolism, generating reactive oxygen species (ROS) intracellularly and lowering the tumor cell apoptotic threshold to ionizing radiation and chemotherapy.NCI Thesaurus | motexafin gadolinium

A synthetic metallotexaphyrin with radiosensitizing and chemosensitizing properties. Motexafin gadolinium accumulates in tumor cells preferentially due to their increased rates of metabolism, generating reactive oxygen species (ROS) intracellularly and lowering the tumor cell apoptotic threshold to ionizing radiation and chemotherapy.

Pharmacyclics Announces Motexafin Gadolinium Improved Survival in ... Dec 8, 2005
Yahoo! News (press release) ...(Nasdaq: PCYC - News) today announced the presentation of preclinical data showing that motexafin gadolinium (MGd), the active chemical agent in Xcytrin ...

Pharmacyclics' Stock Crushed After Failed Phase III Of Xcytrin Dec 19, 2005
BioWorld Online (subscription), ...at the top of the Sunnyvale, Calif.-based company's pipeline, and the trial represents the second Phase III in which Xcytrin (motexafin gadolinium) has failed. ...

Pharmacyclics Announces Presentation and Published Abstracts on ... Dec 6, 2005
PR Newswire (press release), ...(Nasdaq: PCYC) announced today a presentation and multiple published abstracts regarding Xcytrin(R) (motexafin gadolinium) Injection. ...

Pharmacyclics Announces Presentation and Publication of ... Dec 12, 2005
PR Newswire (press release), PCYC) today announced the presentation of preliminary results of a Phase 1 clinical trial, which suggest that Xcytrin(R) (motexafin gadolinium) Injection, when ...

(PRN) - American Greetings Announces Revised Earnings Estimate ... ... Dec 8, 2005
Bolsamania.com, Osaka Gas ... [+. PRN) - Pharmacyclics Announces Motexafin Gadolinium Improved Survival in Animal Models of ALS ... [+. PRN) - Rigel ...

motexafin gadolinium -->